RE: Give it 3 months9 Jul 2016 12:06
Yeah its only going one way, inevitably up. The company acquired Aerocrine for £139 million last year and have over £130 million in the bank. That covers todays. MCap already, never mind all the other core projects. No way was the allergy programme worth two thirds of the company, which is what value has been lost since last months announcement. Drop is way over done. This is a cracking medium and long term hold